Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

BLyS is involved in CLL biology and its low soluble serum levels related to a shorter time to first treatment (TFT). TACI is a BLyS receptor and can be shed from cells' surface and circulate in soluble form (sTACI). We investigated the impact of serum BLyS and sTACI levels at diagnosis in CLL p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kyrtsonis, Marie-Christine, Sarris, Katerina, Koulieris, Efstathios, Maltezas, Dimitrios, Nikolaou, Eftychia, Angelopoulou, Maria K., Bartzis, Vassiliki, Tzenou, Tatiana, Dimou, Maria, Siakandaris, Mariana P., Viniou, Nora A., Sachanas, Sotirios, Kalpadakis, Christina, Sfikakis, Petros P., Pangalis, Gerassimos A., Panayiotidis, Panayiotis
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2014
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138780/
https://ncbi.nlm.nih.gov/pubmed/25162001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/159632
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge